The Postoperative Radiotherapy in N1 Breast Cancer Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,106

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2033

Conditions
RadiotherapyBreast Cancer
Interventions
RADIATION

No PMRT for mastectomy / No regional RT for BCS

"* Regional RT includes high-tangent field, and can include undissected axilla.~* The definition of high-tangent is that the upper margin of the radiotherapy field located within 2 cm of the humeral head to include axillary levels I and II.~* Both hypofractionated and conventionally fractionated radiation therapy are allowed, and 3-dimensional or intensity modulated radiotherapy are allowed. The electron beam can also be used."

RADIATION

PMRT for mastectomy / WBI + Regional RT for BCS

"* Regional RT includes high-tangent field, and can include undissected axilla.~* The definition of high-tangent is that the upper margin of the radiotherapy field located within 2 cm of the humeral head to include axillary levels I and II.~* Both hypofractionated and conventionally fractionated radiation therapy are allowed, and 3-dimensional or intensity modulated radiotherapy are allowed. The electron beam can also be used."

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER